PLERIXAFOR CAN PREDICTABLY MOBILIZE HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE

被引：0
|
作者：
Tarantolo, S. R. [1 ]
McSweeney, P. A. [2 ]
Micallef, I. N. M. [3 ]
Klein, L. M. [4 ]
Calandra, G. [5 ]
Huebner, D. [5 ]
机构：
[1] Nebraske Methodist Hosp, Omaha, NE USA
[2] Rocky Mt Canc Ctr, Denver, CO USA
[3] Mayo Clin, Rochester, MN USA
[4] Advocate Lutheran Gen Hosp, Niles, IL USA
[5] Genzyme Corp, Cambridge, MA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
91
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] PLERIXAFOR CAN PREDICTABLY MOBILIZE HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE
    Micallef, I. N. N.
    Tarantolo, S. R.
    McSweeney, P. A.
    Kjein, L. M.
    Calandra, G.
    Huebner, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 292 - 292
  • [2] PLERIXAFOR CAN PREDICTABLY MOBILIZE HEMATOPOIETIC STEM CELLS IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA PREVIOUSLY TREATED WITH FLUDARABINE AND UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION
    Schriber, J. R.
    McCarty, J.
    McGuirk, J.
    Spitzer, G.
    Uberti, J. P.
    Calandra, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 289 - 289
  • [3] Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    I N M Micallef
    A D Ho
    L M Klein
    S Marulkar
    P J Gandhi
    P A McSweeney
    Bone Marrow Transplantation, 2011, 46 : 350 - 355
  • [4] Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    Micallef, I. N. M.
    Ho, A. D.
    Klein, L. M.
    Marulkar, S.
    Gandhi, P. J.
    McSweeney, P. A.
    BONE MARROW TRANSPLANTATION, 2011, 46 (03) : 350 - 355
  • [5] Erratum: Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    I N M Micallef
    A D Ho
    L M Klein
    S Marulkar
    P J Gandhi
    G Calandra
    P A McSweeney
    Bone Marrow Transplantation, 2011, 46 : 1398 - 1398
  • [6] Results of employing a plerixafor dosing algorithm to mobilize hematopoietic stem cells in patients with multiple myeloma and lymphoma
    Bechtel, T.
    Efebera, Y. A.
    Devine, S. M.
    Elder, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Plerixafor (Mozobil®) Alone to Mobilize Hematopoietic Stem Cells from Multiple Myeloma Patients for Autologous Transplantation
    Flomenberg, Neal
    Comenzo, Raymond L.
    Badel, Karin
    Calandra, Gary
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (05) : 695 - 700
  • [8] Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide (vol 46, pg 350, 2011)
    Micallef, I. N. M.
    Ho, A. D.
    Klein, L. M.
    Marulkar, S.
    Gandhi, P. J.
    Calandra, G.
    McSweeney, P. A.
    BONE MARROW TRANSPLANTATION, 2011, 46 (10) : 1398 - 1398
  • [9] Lenalidomide improves survival in previously treated patients with multiple myeloma
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (01): : 43 - 43
  • [10] Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
    DiPersio, John F.
    Stadtmauer, Edward A.
    Nademanee, Auayporn
    Micallef, Ivana N. M.
    Stiff, Patrick J.
    Kaufman, Jonathan L.
    Maziarz, Richard T.
    Hosing, Chitra
    Frueehauf, Stefan
    Horwitz, Mitchell
    Cooper, Dennis
    Bridger, Gary
    Calandra, Gary
    BLOOD, 2009, 113 (23) : 5720 - 5726
12345